Cargando…

Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors

The mammalian target of rapamycin (mTOR) regulates cell growth by integrating nutrient and growth factor signaling and is strongly implicated in cancer. But mTOR is not an oncogene, and which tumors will be resistant or sensitive to new ATP-competitive mTOR inhibitors now in clinical trials remains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ducker, Gregory S., Atreya, Chloe E., Simko, Jeffry P., Hom, Yun K., Matli, Mary R., Benes, Cyril H., Hann, Byron, Nakakura, Eric K., Bergsland, Emily K., Donner, David B., Settleman, Jeffrey, Shokat, Kevan M., Warren, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982880/ https://www.ncbi.nlm.nih.gov/pubmed/23542178 http://dx.doi.org/10.1038/onc.2013.92

Ejemplares similares

Integrating complex genomic datasets and tumour cell sensitivity profiles to address a 'simple' question: which patients should get this drug?
por: Benes, Cyril, et al.
Publicado: (2009)

PTEN expression is consistent in colorectal cancer primaries and metastases and associates with patient survival
por: Atreya, Chloe E, et al.
Publicado: (2013)

Tissue-restricted inhibition of mTOR using chemical genetics
por: Wassarman, Douglas R., et al.
Publicado: (2022)

Brain-restricted mTOR inhibition with binary pharmacology
por: Zhang, Ziyang, et al.
Publicado: (2022)

Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3
por: Sergina, Natalia V., et al.
Publicado: (2007)

Mitogen Inducible Gene-6 Is a Prognostic Marker for Patients with Colorectal Liver Metastases()()
por: Donner, David B., et al.
Publicado: (2019)

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1
por: Melnyk, James E., et al.
Publicado: (2022)

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
por: Feldman, Morris E, et al.
Publicado: (2009)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

Drugging the undruggable: Ross Cagan interviews Kevan Shokat
por: Cagan, Ross, et al.
Publicado: (2022)

ATP-Driven Contraction of Phage T3 Capsids with DNA Incompletely Packaged In Vivo
por: Serwer, Philip, et al.
Publicado: (2017)

A covalent inhibitor of K-Ras(G12C) induces MHC-I presentation of haptenated peptide neoepitopes targetable by immunotherapy
por: Zhang, Ziyang, et al.
Publicado: (2022)

High thymidylate synthase gene expression predicts poor outcome after resection of hepatocellular carcinoma
por: Donner, David B., et al.
Publicado: (2019)

The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth
por: Soliman, Ghada A, et al.
Publicado: (2020)

mTOR inhibition reprograms cellular proteostasis by regulating eIF3D-mediated selective mRNA translation and promotes cell phenotype switching
por: Shin, Sejeong, et al.
Publicado: (2023)

A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability
por: Guiley, Keelan Z., et al.
Publicado: (2023)

Chemical genetic inhibition of DEAD-box proteins using covalent complementarity
por: Barkovich, Krister J, et al.
Publicado: (2018)

Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways
por: Shi, Yingying, et al.
Publicado: (2015)

Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
por: Ksionda, Olga, et al.
Publicado: (2018)

Correcting for respiratory motion in liver PET/MRI: preliminary evaluation of the utility of bellows and navigated hepatobiliary phase imaging
por: Hope, Thomas A., et al.
Publicado: (2015)

Neuregulin Promotes Incomplete Autophagy of Prostate Cancer Cells That Is Independent of mTOR Pathway Inhibition
por: Schmukler, Eran, et al.
Publicado: (2012)

IFITM proteins assist cellular uptake of diverse linked chemotypes
por: Lou, Kevin, et al.
Publicado: (2022)

Endoplasmic reticulum stress-independent activation of unfolded protein response kinases by a small molecule ATP-mimic
por: Mendez, Aaron S, et al.
Publicado: (2015)

Chemoselective Covalent Modification of K-Ras(G12R) with a Small Molecule Electrophile
por: Zhang, Ziyang, et al.
Publicado: (2022)

Chemical acylation of an acquired serine suppresses oncogenic signaling of K-Ras(G12S)
por: Zhang, Ziyang, et al.
Publicado: (2022)

mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
por: Alain, Tommy, et al.
Publicado: (2012)

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells
por: Blaser, Benjamin, et al.
Publicado: (2012)

Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition
por: Park, Dohyun, et al.
Publicado: (2016)

Structure of the Human Autophagy Initiating Kinase ULK1 in Complex with Potent Inhibitors
por: Lazarus, Michael B., et al.
Publicado: (2014)

Probing the KRas Switch II Groove by Fluorine NMR Spectroscopy
por: Peacock, D. Matthew, et al.
Publicado: (2022)

Duck Tembusu virus induces incomplete autophagy via the ERK/mTOR and AMPK/mTOR signalling pathways to promote viral replication in neuronal cells
por: Wang, Qing, et al.
Publicado: (2023)

Incompleteness
Publicado: (1888)

NAD(H) phosphates mediate tetramer assembly of human C-terminal binding protein (CtBP)
por: Nichols, Jeffry C., et al.
Publicado: (2021)

Chemical Genetic Analysis of Protein Kinase Cascades
por: Alaimo, Peter J., et al.
Publicado: (2002)

A genetically selective inhibitor reveals a ZAP-70 catalytic-independent function in T(REG) cells
por: Au-Yeung, Byron B., et al.
Publicado: (2010)

Successful colonoscopy; completion rates and reasons for incompletion.
por: Mitchell, R. M. S., et al.
Publicado: (2002)

Snail determines the therapeutic response to mTOR kinase inhibitors by transcriptional repression of 4E-BP1
por: Wang, Jun, et al.
Publicado: (2017)

Marine-Derived Natural Products as ATP-Competitive mTOR Kinase Inhibitors for Cancer Therapeutics
por: Parate, Shraddha, et al.
Publicado: (2021)

The incompleteness phenomenon
por: Goldstern, Martin, et al.
Publicado: (1995)

Aspects of incompleteness
por: Lindstrom, Per
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qg9ihmpumfthecq0kma52bl093